US5480772A
(en)
|
1993-02-03 |
1996-01-02 |
Brandeis University |
In vitro activation of a nucleus
|
GB9517779D0
(en)
*
|
1995-08-31 |
1995-11-01 |
Roslin Inst Edinburgh |
Biological manipulation
|
US7304204B2
(en)
|
1995-08-31 |
2007-12-04 |
Roslin Institute |
Ungulates produced by nuclear transfer of G1 cells
|
GB9517780D0
(en)
*
|
1995-08-31 |
1995-11-01 |
Roslin Inst Edinburgh |
Biological manipulation
|
US6025155A
(en)
*
|
1996-04-10 |
2000-02-15 |
Chromos Molecular Systems, Inc. |
Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
|
US6077697A
(en)
|
1996-04-10 |
2000-06-20 |
Chromos Molecular Systems, Inc. |
Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
|
US7696404B2
(en)
|
1996-08-19 |
2010-04-13 |
Advanced Cell Technology, Inc. |
Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions
|
EP0941310A1
(de)
|
1996-10-11 |
1999-09-15 |
THE TEXAS A&M UNIVERSITY SYSTEM |
Verfahren zur erzeugung primordialer keimzellen und transgene tierarten
|
US20090092588A1
(en)
*
|
1997-01-10 |
2009-04-09 |
University Of Massachusetts As Represented By Its Amherst Campus |
Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including parkinson's disease
|
US5945577A
(en)
*
|
1997-01-10 |
1999-08-31 |
University Of Massachusetts As Represented By Its Amherst Campus |
Cloning using donor nuclei from proliferating somatic cells
|
US6215041B1
(en)
*
|
1997-01-10 |
2001-04-10 |
University Of Mmassachusetts |
Cloning using donor nuclei from a non-quiesecent somatic cells
|
US6235969B1
(en)
*
|
1997-01-10 |
2001-05-22 |
University Of Massachusetts |
Cloning pigs using donor nuclei from non-quiescent differentiated cells
|
GB9703550D0
(en)
*
|
1997-02-20 |
1997-04-09 |
Ppl Therapeutics Scotland Ltd |
Cell mediated transgenesis
|
US6011197A
(en)
|
1997-03-06 |
2000-01-04 |
Infigen, Inc. |
Method of cloning bovines using reprogrammed non-embryonic bovine cells
|
CA2797661C
(en)
*
|
1997-04-24 |
2015-06-16 |
University Of Washington |
Targeted gene modification by parvoviral vectors
|
US6921814B2
(en)
|
1997-06-19 |
2005-07-26 |
The General Hospital Corporation |
Torsin, torsin-related genes and methods of detecting neuronal disease
|
EP0989995A2
(de)
|
1997-06-19 |
2000-04-05 |
The General Hospital Corporation |
Torsin, dafür kodierende gene, und deren verwendungen
|
BR9811657A
(pt)
*
|
1997-07-03 |
2000-09-05 |
Univ Massachusetts Public Inst |
Clonagem usando-se núcleos doadores oriundos de células diferenciadas não-carentes de soro
|
WO1999005266A2
(en)
*
|
1997-07-26 |
1999-02-04 |
Wisconsin Alumni Research Foundation |
Trans-species nuclear transfer
|
EP1006790A1
(de)
*
|
1997-08-22 |
2000-06-14 |
Biotechnology and Biological Sciences Research Council |
Verwendung von transposon mariner zur herstellung von transgenen tieren
|
WO1999021415A1
(en)
*
|
1997-10-28 |
1999-05-06 |
Stem Cell Sciences Pty. Ltd. |
Nuclear transfer for production of transgenic animal embryo
|
CA2259368C
(en)
|
1998-01-16 |
2010-10-05 |
Agrobiogen Gmbh |
Efficient nucleus transfer with foetal fibroblasts
|
US6331659B1
(en)
*
|
1998-01-21 |
2001-12-18 |
University Of Hawaii |
Cumulus cells as nuclear donors
|
JP2002511234A
(ja)
*
|
1998-03-16 |
2002-04-16 |
リレグ ピーティーワイ リミテッド |
ブタの核移植
|
AUPP294898A0
(en)
*
|
1998-04-15 |
1998-05-07 |
Monash University |
Method of nuclear transfer
|
GB9808325D0
(en)
*
|
1998-04-20 |
1998-06-17 |
Ltr Ciz Di Associazione Italia |
Source of nuclei for nuclear transfer
|
GB9809178D0
(en)
*
|
1998-04-29 |
1998-07-01 |
Univ Edinburgh |
Nuclear reprogramming of somatic cells
|
AU6218899A
(en)
*
|
1998-10-12 |
2000-05-01 |
Geron Bio-Med Limited |
Porcine oocytes with improved developmental competence
|
EP1375654A3
(de)
*
|
1998-11-02 |
2008-01-16 |
GTC Biotherapeutics, Inc. |
Transgen- und klonierte Saugentiere
|
US6781030B1
(en)
|
1998-11-02 |
2004-08-24 |
Trustee Of Tufts College, Ballou Hall |
Methods for cloning mammals using telophase oocytes
|
AU2003204830B2
(en)
*
|
1998-11-02 |
2007-08-30 |
Gtc Biotherapeutics, Inc. |
Transgenic and cloned mammals
|
US6580017B1
(en)
|
1998-11-02 |
2003-06-17 |
Genzyme Transgenics Corporation |
Methods of reconstructed goat embryo transfer
|
EP1127113A2
(de)
*
|
1998-11-02 |
2001-08-29 |
Genzyme Transgenics Corporation |
Transgen- und klonierte saugentiere
|
EP1130961B1
(de)
|
1998-11-19 |
2009-04-08 |
Pharming Intellectual Property BV |
Stabilisierung der milch transgener tieren
|
US6700037B2
(en)
|
1998-11-24 |
2004-03-02 |
Infigen, Inc. |
Method of cloning porcine animals
|
US6258998B1
(en)
|
1998-11-24 |
2001-07-10 |
Infigen, Inc. |
Method of cloning porcine animals
|
NZ550899A
(en)
*
|
1999-01-13 |
2008-07-31 |
Revivicor Inc |
Double nuclear transfer method and the production of a non human animal thereby
|
GB9903804D0
(en)
*
|
1999-02-20 |
1999-04-14 |
Univ Sheffield |
Pluripotential cells-2
|
GB9903805D0
(en)
*
|
1999-02-20 |
1999-04-14 |
Univ Sheffield |
Pluripotential cells-1
|
WO2000050443A2
(en)
|
1999-02-26 |
2000-08-31 |
Millennium Pharmaceutcals, Inc. |
Secreted proteins and uses thereof
|
US20020012660A1
(en)
*
|
1999-03-04 |
2002-01-31 |
Alan Colman |
Method of preparing a somatic cells for nuclear transfer
|
ATE452973T1
(de)
*
|
1999-03-04 |
2010-01-15 |
Revivicor Inc |
Genetische veränderung von somatischen zellen und deren verwendungen
|
AU777799B2
(en)
*
|
1999-04-28 |
2004-10-28 |
Valorisation-Recherche, Societe En Commandite |
Telophase enucleated oocytes for nuclear transfer
|
DE69934914T2
(de)
*
|
1999-06-04 |
2007-10-18 |
Istituto Zootecnico E Caseario Per La Sardegna |
Verfahren zur rekonstruktion eines nicht-menschlichen tierischen embryos mittels kerntransfer und die herstellung des tieres daraus.
|
EP1194570A1
(de)
|
1999-06-23 |
2002-04-10 |
PPL Therapeutics (Scotland) Limited |
Lysozym- enthaltende fusionsproteine
|
JP2003503044A
(ja)
*
|
1999-06-30 |
2003-01-28 |
ワン,ウー−サク |
種間核移植技術を用いたヒトクローン胚の作製方法
|
US7291714B1
(en)
|
1999-06-30 |
2007-11-06 |
Millennium Pharmaceuticals, Inc. |
Glycoprotein VI and uses thereof
|
US6590139B1
(en)
|
1999-06-30 |
2003-07-08 |
Woo-Suk Hwang |
Method for producing cloned cows
|
AU753209B2
(en)
*
|
1999-06-30 |
2002-10-10 |
Seoul National University Industry Foundation |
Method for producing cloned tigers by employing inter-species nuclear transplantation technique
|
EP1196426A4
(de)
|
1999-06-30 |
2003-09-03 |
Advanced Cell Tech Inc |
Zytoplasmatischer transfer zur de-differenzierung von gefässzellen
|
WO2001014557A1
(en)
|
1999-08-23 |
2001-03-01 |
Dana-Farber Cancer Institute, Inc. |
Pd-1, a receptor for b7-4, and uses therefor
|
EP2275559A3
(de)
|
1999-09-28 |
2011-03-23 |
Shire Human Genetic Therapies, Inc. |
Optimierte Boten-RNA (mRNA)
|
WO2002064799A2
(en)
|
1999-09-28 |
2002-08-22 |
Transkaryotic Therapies, Inc. |
Optimized messenger rna
|
ATE364693T1
(de)
*
|
1999-09-30 |
2007-07-15 |
Gtc Biotherapeutics Inc |
Verfahren zur herstellung von nicht-humanen geklonten und transgenen säugetieren
|
US7074983B2
(en)
*
|
1999-11-19 |
2006-07-11 |
Kirin Beer Kabushiki Kaisha |
Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin
|
WO2001035735A1
(en)
*
|
1999-11-19 |
2001-05-25 |
Hematech, Llc |
Production of ungulates, preferably bovines that produce human immunoglobulins
|
US7820878B2
(en)
*
|
1999-11-19 |
2010-10-26 |
Kyowa Hakko Kirin Co., Ltd. |
Production of ungulates, preferably bovines that produce human immunoglobulins
|
KR100417566B1
(ko)
*
|
1999-11-19 |
2004-02-05 |
한국생명공학연구원 |
체세포 핵치환 복제수정란의 대량생산방법
|
US7253334B2
(en)
*
|
2000-12-22 |
2007-08-07 |
Aurox, Llc |
Methods for cloning non-human mammals using reprogrammed donor chromatin or donor cells
|
US7414170B2
(en)
*
|
1999-11-19 |
2008-08-19 |
Kirin Beer Kabushiki Kaisha |
Transgenic bovines capable of human antibody production
|
US6635802B1
(en)
*
|
2000-01-10 |
2003-10-21 |
The Texas A&M University System |
Nuclear transfer using cells cultured in serum starvation media containing apoptosis inhibitors
|
GB0001401D0
(en)
*
|
2000-01-22 |
2000-03-08 |
Univ Edinburgh |
Methods for amplifying genetic material and use thereof
|
EP1356031B1
(de)
|
2000-03-15 |
2011-07-27 |
The University Of Georgia Research Foundation, Inc. |
Effektive kernumprogrammierung in säugetieren
|
US20040033600A1
(en)
|
2001-03-21 |
2004-02-19 |
Palli Subba Reddy |
Ecdysone receptor-based inducible gene expression system
|
GB2360522A
(en)
|
2000-03-24 |
2001-09-26 |
Geron Corp |
A strategy for maintaining pregnancy
|
AU2001261650A1
(en)
*
|
2000-05-15 |
2001-11-26 |
Geron Corporation |
Ovine tissue for xenotransplantation
|
AU2001271731A1
(en)
|
2000-06-28 |
2002-01-08 |
Dana-Farber Cancer Institute, Inc. |
PD-L2 molecules: novel PD-1 ligands and uses therefor
|
AU2001278204A1
(en)
*
|
2000-08-01 |
2002-02-13 |
Xy Genetics, Llc |
Methods of selecting and cloning animals
|
AU8470301A
(en)
|
2000-08-03 |
2002-02-18 |
Wim-Van Schooten |
Production of humanized antibodies in transgenic animals
|
AU2001284948A1
(en)
|
2000-08-15 |
2002-02-25 |
Board Of Trustees Of The University Of Illinois |
Animals expressing exogenous igf-i in their milk
|
WO2002019811A2
(en)
*
|
2000-09-06 |
2002-03-14 |
Nexia Biotechnologies, Inc. |
Generation of transgenic animals using nuclear transfer and oocytes at the germinal vesicle stage
|
US8105825B2
(en)
*
|
2000-10-03 |
2012-01-31 |
Intrexon Corporation |
Multiple inducible gene regulation system
|
FR2814642B1
(fr)
|
2000-10-03 |
2005-07-01 |
Ass Pour Le Dev De La Rech En |
Souris transgenique pour la recombinaison ciblee mediee par la cre-er modifiee
|
US20040029825A1
(en)
*
|
2001-10-03 |
2004-02-12 |
Davies Christopher J |
Methods of minimizing immunological rejection of a nuclear transfer fetus
|
CA2429722A1
(en)
|
2000-11-28 |
2002-06-06 |
Wyeth |
Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
|
EP1343912A2
(de)
|
2000-11-28 |
2003-09-17 |
Wyeth |
Expressionsanalyse von kiaa nukleinsäuren und polypeptiden, geeignet zur diagnose und zur behandlung von prostatakrebs
|
US7491534B2
(en)
|
2000-12-22 |
2009-02-17 |
Kirin Holdings Kabushiki Kaisha |
Methods for altering cell fate to generate T-cells specific for an antigen of interest
|
ATE466089T1
(de)
|
2000-12-22 |
2010-05-15 |
Agronomique Inst Nat Rech |
Positionsunabhängige und gewebespezifische expression eines transgens in der milch eines transgen-tieres
|
US20020142397A1
(en)
|
2000-12-22 |
2002-10-03 |
Philippe Collas |
Methods for altering cell fate
|
EP1860199B1
(de)
|
2001-01-12 |
2014-03-05 |
Exelixis, Inc. |
Modulierte Signalisierung von Insulinrezeptoren
|
US20050177883A1
(en)
|
2001-01-30 |
2005-08-11 |
Rebholtz Paul C. |
Systems of transferring embryos and managing recipients
|
WO2002062131A2
(en)
*
|
2001-02-02 |
2002-08-15 |
Infigen, Inc. |
Method of cloning transgenic mammalian animals using pseudonuclei
|
WO2002066614A2
(en)
*
|
2001-02-20 |
2002-08-29 |
Rheogene Holdings, Inc. |
Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system
|
WO2002068955A1
(en)
|
2001-02-23 |
2002-09-06 |
Elan Pharmaceuticals, Inc. |
Transgenic knockouts of bace-1
|
JP2002262716A
(ja)
*
|
2001-03-07 |
2002-09-17 |
National Agricultural Research Organization |
株化細胞を用いて家畜個体を作出する方法
|
WO2002072762A2
(en)
*
|
2001-03-08 |
2002-09-19 |
Advanced Cell Technology, Inc. |
Use of rna interference for the creation of lineage specific es and other undifferentiated cells and production of differentiated cells in vitro by co-culture
|
AUPR363701A0
(en)
|
2001-03-09 |
2001-04-05 |
Garelag Pty Ltd |
Method for the production of nuclear transfer embryos
|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
US7126039B2
(en)
*
|
2001-03-21 |
2006-10-24 |
Geron Corporation |
Animal tissue with carbohydrate antigens compatible for human transplantation
|
EP1370132A2
(de)
*
|
2001-03-21 |
2003-12-17 |
Geron Corporation |
Verwendung von telomerase reverse-transkriptase zur herstellung von homozygote "knock-out" tieren
|
WO2002078449A2
(en)
*
|
2001-04-02 |
2002-10-10 |
Advanced Cell Technology, Inc. |
Method for facilitating the production of differentiated cell types and tissues from embryonic and adult pluripotent and multipotent cells
|
MXPA03008959A
(es)
|
2001-04-02 |
2004-10-15 |
Wyeth Corp |
Pd-1, un receptor para b7-4 y sus usos.
|
MXPA03009415A
(es)
|
2001-04-16 |
2004-01-29 |
Wyeth Corp |
ESTRUCTURAS NOVEDOSAS DE LECTURA ABIERTA DE STREPTOCOCCUS PNEUMONIAE QUE CODIFICAN ANTIGENOS DE POLIPePTIDOS Y USOS DE LAS MISMAS.
|
US20030153044A1
(en)
*
|
2001-05-14 |
2003-08-14 |
Monika Liljedahl |
Tissues or organs for use in xenotransplantation
|
WO2002092791A1
(en)
*
|
2001-05-14 |
2002-11-21 |
Stell |
Tissues or organs for use in xenotransplantation
|
US20030101469A1
(en)
*
|
2001-07-09 |
2003-05-29 |
Kenneth Bondioli |
Cloned non-human mammals from contact inhibited donor cells
|
EP1900815B1
(de)
|
2001-07-12 |
2016-09-07 |
University of Massachusetts |
In-vivo-Herstellung kleiner interferierender und Genverstummung vermittelnder RNAs
|
KR20040022449A
(ko)
|
2001-07-12 |
2004-03-12 |
유니버시티 오브 매사추세츠 |
유전자 불활성화를 매개하는 소형 간섭 rna의 생체내제조
|
AU2002326483A1
(en)
*
|
2001-07-31 |
2003-02-17 |
Simon Eric Aspland |
Genetically modified cows having reduced susceptibility to mad cow disease
|
US20030211603A1
(en)
*
|
2001-08-14 |
2003-11-13 |
Earp David J. |
Reprogramming cells for enhanced differentiation capacity using pluripotent stem cells
|
CA2466415C
(en)
|
2001-11-09 |
2020-01-21 |
Dana-Farber Cancer Institute, Inc. |
Pgc-1.beta., a novel pgc-1 homologue and uses therefor
|
US20050170506A1
(en)
*
|
2002-01-16 |
2005-08-04 |
Primegen Biotech Llc |
Therapeutic reprogramming, hybrid stem cells and maturation
|
US20030134422A1
(en)
*
|
2002-01-16 |
2003-07-17 |
Sayre Chauncey Bigelow |
Stem cell maturation for all tissue lines
|
US20050090004A1
(en)
*
|
2003-01-16 |
2005-04-28 |
Sayre Chauncey B. |
Stem cell maturation for all tissue lines
|
WO2003087341A2
(en)
|
2002-01-23 |
2003-10-23 |
The University Of Utah Research Foundation |
Targeted chromosomal mutagenesis using zinc finger nucleases
|
KR100502695B1
(ko)
*
|
2002-02-28 |
2005-07-25 |
한국생명공학연구원 |
형질전환 효율이 향상된 복제수정란의 대량 생산 방법
|
US20030232410A1
(en)
*
|
2002-03-21 |
2003-12-18 |
Monika Liljedahl |
Methods and compositions for using zinc finger endonucleases to enhance homologous recombination
|
GB0207299D0
(en)
*
|
2002-03-28 |
2002-05-08 |
Franks Christopher R |
Stem cell therapy
|
JP2005528095A
(ja)
*
|
2002-04-01 |
2005-09-22 |
ジーティーシー バイオセラピューティックス インコーポレイテッド |
哺乳類種における核移植に使用するための細胞株を選択する方法
|
US20030207448A1
(en)
*
|
2002-05-06 |
2003-11-06 |
Revera Gregory Henry |
Methodologies for the creation of pluripotent or multipotent human stem cells without creating or destroying a human embryo
|
GB0211904D0
(en)
*
|
2002-05-23 |
2002-07-03 |
Medical Res Council |
Nuclear transfer
|
US7410797B2
(en)
*
|
2002-06-11 |
2008-08-12 |
Ogle Roy C |
Meningeal-derived stem cells
|
US7612250B2
(en)
*
|
2002-07-29 |
2009-11-03 |
Trustees Of Tufts College |
Nuclear transfer embryo formation method
|
EP2314716A1
(de)
|
2002-08-20 |
2011-04-27 |
Millennium Pharmaceuticals, Inc. |
Zusammensetzungen, Kits und Verfahren zur Identifizierung, Beurteilung, Vorbeugung und Therapie von Gebärmutterhalskrebs
|
EP2806025B1
(de)
|
2002-09-05 |
2019-04-03 |
California Institute of Technology |
Verwendung von Zinkfingernukleasen zur Stimulierung von Gentargeting
|
US7122361B2
(en)
|
2002-10-10 |
2006-10-17 |
Wyeth |
Compositions employing a novel human kinase
|
US20040077077A1
(en)
*
|
2002-10-18 |
2004-04-22 |
Xiangzhong Yang |
Novel methods for the production of cloned mammals, mammals cloned according to the methods, and methods of use of same
|
CA2503491A1
(en)
|
2002-10-24 |
2004-05-06 |
Wyeth |
Calcineurin-like human phosphoesterase
|
US7429690B2
(en)
|
2002-11-08 |
2008-09-30 |
Kirin Holdings Kabushiki Kaisha |
Transgenic bovines having reduced prion protein production
|
US7611839B2
(en)
|
2002-11-21 |
2009-11-03 |
Wyeth |
Methods for diagnosing RCC and other solid tumors
|
US7297525B2
(en)
|
2002-11-27 |
2007-11-20 |
Wyeth |
Composition employing a novel human kinase
|
EP1578192A4
(de)
*
|
2002-12-10 |
2006-03-29 |
Gtc Biotherapeutics Inc |
Verfahren und system zur verwendung vongeklonten kerntransferembryonen als zellspender für einen zusätzlichenkerntransfer
|
AU2003299818A1
(en)
|
2002-12-20 |
2004-07-22 |
Applera Corporation |
Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
|
WO2004061423A2
(en)
|
2003-01-06 |
2004-07-22 |
Wyeth |
Compositions and methods for diagnosing and treating colon cancers
|
FR2855183B1
(fr)
|
2003-05-23 |
2005-08-12 |
Agronomique Inst Nat Rech |
Procede de clonage du rat par transfert nucleaire
|
PL1633767T3
(pl)
|
2003-06-02 |
2019-07-31 |
University Of Massachusetts |
Sposoby i kompozycje do kontrolowania wydajności wyciszania rna
|
ES2864206T3
(es)
|
2003-06-02 |
2021-10-13 |
Univ Massachusetts |
Métodos y composiciones para mejorar la eficacia y la especificidad del ARNi
|
US8409861B2
(en)
*
|
2003-08-08 |
2013-04-02 |
Sangamo Biosciences, Inc. |
Targeted deletion of cellular DNA sequences
|
US20120196370A1
(en)
|
2010-12-03 |
2012-08-02 |
Fyodor Urnov |
Methods and compositions for targeted genomic deletion
|
US11311574B2
(en)
|
2003-08-08 |
2022-04-26 |
Sangamo Therapeutics, Inc. |
Methods and compositions for targeted cleavage and recombination
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
JP2007502119A
(ja)
|
2003-08-14 |
2007-02-08 |
エクセリクシス, インク. |
βカテニン経路のモディファイヤーとしてのUPs及び使用方法
|
KR20060120652A
(ko)
|
2003-10-07 |
2006-11-27 |
밀레니엄 파머슈티컬스 인코퍼레이티드 |
난소암의 확인, 평가, 예방 및 치료를 위한 핵산 분자 및단백질
|
WO2005046450A2
(en)
|
2003-11-12 |
2005-05-26 |
Children's Hospital Medical Center |
Method for diagnosis and treatment of pulmonary disorders
|
CA3048093A1
(en)
|
2003-11-26 |
2005-06-23 |
Celera Corporation |
Single nucleotide polymorphisms associated with cardiovascular disorders and statin response, methods of detection and uses thereof
|
US7972854B2
(en)
|
2004-02-05 |
2011-07-05 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
US7420099B2
(en)
*
|
2004-04-22 |
2008-09-02 |
Kirin Holdings Kabushiki Kaisha |
Transgenic animals and uses thereof
|
EP2412826B1
(de)
|
2004-05-07 |
2014-01-08 |
Celera Corporation |
Genetischer Polymorphismus und Leberfibrose, Verfahren zur Erkennung und Verwendung davon
|
JP2006081542A
(ja)
*
|
2004-08-18 |
2006-03-30 |
Institute Of Physical & Chemical Research |
クローン哺乳動物の作成方法
|
US8889639B2
(en)
|
2004-10-22 |
2014-11-18 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating PGC-1β to treat lipid-related diseases and disorders
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
CN1274829C
(zh)
|
2004-12-10 |
2006-09-13 |
四川大学华西医院 |
抗eb病毒所致肿瘤多肽及其应用与制备方法
|
JP5590697B2
(ja)
|
2005-03-11 |
2014-09-17 |
セレラ コーポレーション |
冠動脈心疾患に関連する遺伝的多型、その検出方法および使用
|
US20060286666A1
(en)
*
|
2005-06-17 |
2006-12-21 |
Kang Ji Y |
Methods and apparatuses for culturing stem cell using biomaterial shell
|
EP1924697A2
(de)
*
|
2005-06-29 |
2008-05-28 |
Cameron Clokie |
Produktion von bmps (bone morphogenic proteins) in transgenen säugern
|
KR100733012B1
(ko)
|
2005-07-26 |
2007-06-28 |
재단법인서울대학교산학협력재단 |
복제된 개과 동물 및 이의 생산 방법
|
AU2006292827B2
(en)
|
2005-08-09 |
2013-02-14 |
Revivicor, Inc. |
Transgenic ungulates expressing CTLA4-IG and uses thereof
|
WO2007030820A2
(en)
|
2005-09-09 |
2007-03-15 |
The Johns Hopkins University |
Manipulation of regulatory t cell and dc function by targeting neuritin gene using antibodies, agonists and antagonists
|
US8921109B2
(en)
|
2005-09-19 |
2014-12-30 |
Histogenics Corporation |
Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
|
US7799530B2
(en)
|
2005-09-23 |
2010-09-21 |
Celera Corporation |
Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
|
US7695911B2
(en)
|
2005-10-26 |
2010-04-13 |
Celera Corporation |
Genetic polymorphisms associated with Alzheimer's Disease, methods of detection and uses thereof
|
WO2007124019A2
(en)
|
2006-04-21 |
2007-11-01 |
Gtc Biotherapeutics, Inc. |
Methods and products related to the transfer of molecules from blood to the mammary gland
|
CN102719444B
(zh)
|
2006-09-01 |
2016-12-14 |
人类多细胞株治疗学公司 |
人或人源化免疫球蛋白在非人转基因动物中增强的表达
|
WO2008033239A2
(en)
|
2006-09-11 |
2008-03-20 |
Applera |
Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
|
WO2008051511A2
(en)
|
2006-10-20 |
2008-05-02 |
Applera Corporation |
Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
|
KR101398220B1
(ko)
*
|
2006-10-30 |
2014-05-22 |
건국대학교 산학협력단 |
형질전환 배아 생성방법
|
US20100205678A1
(en)
*
|
2007-01-05 |
2010-08-12 |
Overstrom Eric W |
Oocyte spindle-associated factors improve somatic cell cloning
|
KR100829426B1
(ko)
|
2007-01-17 |
2008-05-15 |
재단법인서울대학교산학협력재단 |
복제개의 생산 방법
|
US20080222745A1
(en)
*
|
2007-03-07 |
2008-09-11 |
Utah State University |
Colcemid-Treatment of Oocytes to enhance Nuclear Transfer Cloning
|
KR100868245B1
(ko)
|
2007-05-29 |
2008-11-11 |
강원대학교산학협력단 |
데메콜친 처리에 의한 효율적인 복제 동물의 생산방법
|
WO2009055656A2
(en)
|
2007-10-26 |
2009-04-30 |
Centocor, Inc. |
Vectors, host cells, and methods of production and uses
|
US8039212B2
(en)
|
2007-11-05 |
2011-10-18 |
Celera Corporation |
Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
|
JP2011508600A
(ja)
|
2008-01-04 |
2011-03-17 |
ソウル ナショナル ユニバーシティ インダストリー ファウンデーション |
形質転換された複製犬の生産方法
|
US20090221620A1
(en)
|
2008-02-20 |
2009-09-03 |
Celera Corporation |
Gentic polymorphisms associated with stroke, methods of detection and uses thereof
|
EP2265730B1
(de)
|
2008-03-12 |
2018-06-06 |
The Rockefeller University |
Verfahren und vorrichtungen zur erstellung von translationsprofilen und molekularen phänotypisierung
|
US8288094B2
(en)
|
2008-04-09 |
2012-10-16 |
Institut Pasteur |
APOBEC3 mediated DNA editing
|
US8557773B2
(en)
|
2008-05-02 |
2013-10-15 |
Laboratoire Francais Du Fractionnement Et Des Biotechnologies |
Treatment of bleeding with low half-life fibrinogen
|
EP2295538B1
(de)
*
|
2008-07-07 |
2015-10-21 |
Takara Bio Inc. |
Verfahren zur herstellung einer pluripotenten stammzelle
|
EP3093351B1
(de)
|
2008-07-09 |
2018-04-18 |
Celera Corporation |
Mit kardiovaskulären krankheiten assoziierte, genetische polymorphismen, verfahren zum nachweis und verwendungen davon
|
US9181315B2
(en)
|
2009-01-08 |
2015-11-10 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for induced brown fat differentiation
|
WO2010124200A2
(en)
|
2009-04-23 |
2010-10-28 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for cancer
|
EP2267153A1
(de)
|
2009-05-26 |
2010-12-29 |
Université Claude Bernard Lyon 1 |
Identifizierung der Netrin-1-Rezeptor-unc5c-Genmutation bei festen Krebsen
|
US9314005B2
(en)
|
2009-07-01 |
2016-04-19 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for severe combined immunodeficiency (SCID)
|
WO2011011678A2
(en)
|
2009-07-24 |
2011-01-27 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for cytokine-cytokine signaling pathways
|
US20110145936A1
(en)
|
2009-07-30 |
2011-06-16 |
Ostertag Eric M |
Genetically Modified Rat Models for Pharmacokinetics
|
US20110035816A1
(en)
|
2009-08-05 |
2011-02-10 |
Ostertag Eric M |
Genetically Modified Rat Models for Drug Metabolism
|
US20120151609A1
(en)
|
2009-08-20 |
2012-06-14 |
Ostertag Eric M |
Genetically Modified Rat Models for Pain
|
US9420770B2
(en)
|
2009-12-01 |
2016-08-23 |
Indiana University Research & Technology Corporation |
Methods of modulating thrombocytopenia and modified transgenic pigs
|
WO2011091134A2
(en)
|
2010-01-22 |
2011-07-28 |
Dana-Farber Cancer Institute, Inc. |
Compositions,kits, and methods for identification, assessment, prevention, and therapy of metabolic disorders
|
TWI518325B
(zh)
|
2010-02-04 |
2016-01-21 |
自治醫科大學 |
對alk抑制劑具有先抗性或後抗性癌症的識別、判斷和治療
|
US10745467B2
(en)
|
2010-03-26 |
2020-08-18 |
The Trustees Of Dartmouth College |
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
|
US20150231215A1
(en)
|
2012-06-22 |
2015-08-20 |
Randolph J. Noelle |
VISTA Antagonist and Methods of Use
|
CA2794483C
(en)
|
2010-03-26 |
2020-07-07 |
Trustees Of Dartmouth College |
Vista regulatory t cell mediator protein, vista binding agents and use thereof
|
US8383793B2
(en)
|
2010-04-15 |
2013-02-26 |
St. Jude Children's Research Hospital |
Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitors
|
US20110269735A1
(en)
|
2010-04-19 |
2011-11-03 |
Celera Corporation |
Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof
|
US8956865B2
(en)
|
2010-08-11 |
2015-02-17 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Methods of growing an embryo to a blastocyst stage of development
|
US20120108651A1
(en)
|
2010-11-02 |
2012-05-03 |
Leiden University Medical Center (LUMC) Acting on Behalf of Academic Hospital Leiden (AZL) |
Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
|
WO2012071393A2
(en)
|
2010-11-23 |
2012-05-31 |
The New York Stem Cell Foundation |
Method for producing pluripotent stem cells
|
NZ759163A
(en)
|
2011-02-14 |
2023-03-31 |
Revivicor Inc |
Genetically modified pigs for xenotransplantation of vascularized xenografts and derivatives thereof
|
WO2012129198A1
(en)
|
2011-03-23 |
2012-09-27 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for obesity and diabetes
|
CA2836288A1
(en)
|
2011-05-16 |
2012-11-22 |
The Curators Of The University Of Missouri |
Porcine reproductive and respiratory syndrome virus resistant animals
|
US8969519B2
(en)
|
2011-09-13 |
2015-03-03 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for brown fat induction and activity using FNDC5
|
CN102391989A
(zh)
*
|
2011-10-12 |
2012-03-28 |
扬州大学 |
转基因动物重组产物精确分析检验方法
|
EP3196214B1
(de)
|
2012-02-15 |
2019-07-31 |
Novo Nordisk A/S |
Antikörper, die den auslösenden rezeptor binden und blockieren, der auf myeloid-zellen-1 (trem-1) exprimiert ist
|
RS57827B1
(sr)
|
2012-02-15 |
2018-12-31 |
Novo Nordisk As |
Antitela koja vezuju protein 1 prepoznavanja peptidoglikana
|
US9550830B2
(en)
|
2012-02-15 |
2017-01-24 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
|
US9890215B2
(en)
|
2012-06-22 |
2018-02-13 |
King's College London |
Vista modulators for diagnosis and treatment of cancer
|
FI3421486T3
(fi)
|
2012-06-22 |
2023-12-15 |
Dartmouth College |
Uusia vista-ig-rakenteita ja vista-ig:n käyttö autoimmuuni-, allergia- ja tulehdushäiriöiden hoitamiseksi
|
WO2014039983A1
(en)
|
2012-09-07 |
2014-03-13 |
The Trustees Of Dartmouth College |
Vista modulators for diagnosis and treatment of cancer
|
US20140115728A1
(en)
|
2012-10-24 |
2014-04-24 |
A. Joseph Tector |
Double knockout (gt/cmah-ko) pigs, organs and tissues
|
CA2900909A1
(en)
|
2013-02-13 |
2014-08-21 |
Laboratoire Francais Du Fractionnement Et Des Biotechnologies |
Highly galactosylated anti-tnf-.alpha. antibodies and uses thereof
|
CN105263319A
(zh)
|
2013-02-13 |
2016-01-20 |
法国化学与生物科技实验室 |
具有经修饰的糖基化的蛋白及其生产方法
|
EP2993234B1
(de)
|
2013-04-30 |
2018-10-10 |
Konkuk University Industrial Cooperation Corp. |
Cmp-acetylneuraminsäure-hydroxylase-targeting-vektor, transgenes tier zur mit dem vektor eingeführten xenotransplantation und verfahren zur herstellung davon
|
US11014987B2
(en)
|
2013-12-24 |
2021-05-25 |
Janssen Pharmaceutics Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
JP6590810B2
(ja)
|
2013-12-24 |
2019-10-16 |
ヤンセン ファーマシューティカ エヌブイ |
抗vista抗体および断片
|
WO2015191881A2
(en)
|
2014-06-11 |
2015-12-17 |
Green Kathy A |
Use of vista agonists and antagonists to suppress or enhance humoral immunity
|
LT3172232T
(lt)
|
2014-07-17 |
2024-02-12 |
Novo Nordisk A/S |
Į vietą nukreipta trem-1 antikūnų mutagenezė, skirta klampumui sumažinti
|
US10077420B2
(en)
|
2014-12-02 |
2018-09-18 |
Histogenics Corporation |
Cell and tissue culture container
|
CA2969730A1
(en)
|
2014-12-05 |
2016-06-09 |
Immunext, Inc. |
Identification of vsig8 as the putative vista receptor and its use thereof to produce vista/vsig8 modulators
|
PT3230320T
(pt)
|
2014-12-09 |
2021-01-08 |
Regeneron Pharma |
Animais não humanos tendo um gene do cluster humanizado de diferenciação 274
|
CN104823921A
(zh)
*
|
2015-05-21 |
2015-08-12 |
蒙汉勤 |
一种用于人体烧伤皮肤移植及医学实验的小型香猪的饲养技术
|
BR112017027870A2
(pt)
|
2015-06-24 |
2018-08-28 |
Janssen Pharmaceutica Nv |
anticorpos e fragmentos anti-vista
|
EP3331355B1
(de)
|
2015-08-06 |
2024-04-03 |
The Curators of the University of Missouri |
Gegen das reproduktive und respiratorische schweinesyndromvirus (prrsv) resistente schweine und zellen mit modifizierten cd163-genen
|
CA3002676A1
(en)
|
2015-10-29 |
2017-05-04 |
Dana-Farber Cancer Institute, Inc. |
Methods for identification, assessment, prevention, and treatment of metabolic disorders using pm20d1 and n-lipidated amino acids
|
WO2017137830A1
(en)
|
2016-02-12 |
2017-08-17 |
Janssen Pharmaceutica Nv |
Anti-vista (b7h5) antibodies
|
UA125382C2
(uk)
|
2016-04-15 |
2022-03-02 |
Імьюнекст Інк. |
Антитіла проти людського vista та їх застосування
|
JP2021519594A
(ja)
|
2018-04-02 |
2021-08-12 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
抗trem−1抗体およびその使用
|
AU2019247490A1
(en)
|
2018-04-06 |
2020-10-22 |
Children's Medical Center Corporation |
Compositions and methods for somatic cell reprogramming and modulating imprinting
|
US11160260B2
(en)
|
2018-04-17 |
2021-11-02 |
The Curators Of The University Of Missouri |
Methods for protecting porcine fetuses from infection with porcine reproductive and respiratory syndrome virus (PRRSV)
|
WO2020041360A1
(en)
|
2018-08-21 |
2020-02-27 |
Quidel Corporation |
Dbpa antibodies and uses thereof
|
AU2020408213A1
(en)
|
2019-12-19 |
2022-06-23 |
Quidel Corporation |
Monoclonal antibody fusions
|
AU2021385081A1
(en)
|
2020-11-20 |
2023-06-29 |
Revivicor, Inc. |
Multi-transgenic pigs with growth hormone receptor knockout for xenotransplantation
|
US20230255185A1
(en)
|
2021-09-20 |
2023-08-17 |
Revivicor, Inc. |
Multitransgenic pigs comprising ten genetic modifications for xenotransplantation
|